Seasonal Tailwind — september med 11.3% (mag 2/3) · posClose 60.00% (rel 1/3) · n10 ×1 = 6.3
Founder-Led — founder/CEO led
About BeiGene, Ltd.
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVA… Read full Trend Edge analysis →
Founder-Led: Yes — John V. Oyler (Co-Founder, Chairman & Chief Executive Officer), Xiaodong Wang (Co-Founder, Chairman of the Scientific Advisory Board)
Key Metrics
Current Price
$374.47
Market Cap
$41.76B
Float
81.0M
Shares Outstanding
104.3M
P/E (Forward)
48.78
P/E (TTM)
66.16
Price/Sales (TTM)
6.81
vs. Analyst Target
+15.6% to analyst PT
Profit Margin
10.70%
Operating Margin (TTM)
19.06%
Revenue (TTM)
$6.13B
Earnings Growth (YoY)
166.70%
Dividend Rate
None
Analyst Target Price
$433.02 (24 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$309M
-$1.62B
$238M
-$1.63B
2021
$1.18B
-$1.46B
$1.01B
-$1.39B
2022
$1.42B
-$2.00B
$1.13B
-$1.89B
2023
$2.46B
-$882M
$2.08B
-$738M
2024
$3.81B
-$645M
$3.22B
-$361M
2025
$5.34B
$287M
$4.67B
$617M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
$1.41B
$125M
Dec 2025
$1.50B
$66.5M
Mar 2026
$1.51B
$227M
Jun 2026
$1.71B
$237M
Ownership & Float
Insider Ownership
17.3%
Institutional Ownership
33.1%
Short Float
1.1%
% of All Funds Holding
3.22%
Number of Funds Holding
283
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$317.05
Near-term / short-term trend
Weekly
40-Week SMA
$314.89
Medium-term trend
Weekly
80-Week SMA
$297.07
Cyclical trend (business cycle)
Weekly
200-Week SMA
$235.22
Secular trend (multi-year)
Monthly
10-Month SMA
$315.74
Near-term monthly trend
Monthly
20-Month SMA
$296.61
Medium-term monthly trend
Monthly
40-Month SMA
$239.69
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$286.00
support
1.42x
0 months ago
$317.00
support
1.13x
0 months ago
$245.00
support
1.02x
12 months ago
$221.00
support
1.49x
17 months ago
$183.00
support
1.08x
18 months ago
Historical Earnings Reactions (42 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.05%
-0.03%
45.24%
7.88%
-5.12%
1 Day
0.34%
-0.19%
42.86%
12.12%
-10.36%
1 Week
1.19%
2.02%
64.29%
15.33%
-16.06%
2 Weeks
0.32%
-0.69%
45.24%
31.98%
-31.47%
1 Month
0.06%
-1.28%
46.34%
32.84%
-25.85%
Next earnings: October 24, 2026 (60 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
8.4%
60.0%
10
Feb
2.8%
60.0%
10
Mar
-2.9%
36.4%
11
Apr
1.9%
36.4%
11
May
-2.0%
36.4%
11
Jun
1.0%
45.5%
11
Jul
14.4%
81.8%
11
Aug
3.4%
60.0%
10
Sep
7.0%
60.0%
10
Oct
-0.5%
50.0%
10
Nov
6.4%
60.0%
10
Dec
-4.4%
30.0%
10
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.08%
50.9%
495
Tuesday
0.36%
53.6%
545
Wednesday
0.26%
52.6%
542
Thursday
-0.03%
47.9%
534
Friday
0.11%
49.8%
532
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 33.1%
Insider Transactions — Smart Summary
Total insider ownership: 17.3%
Founder-led management: John V. Oyler (Co-Founder, Chairman & Chief Executive Officer), Xiaodong Wang (Co-Founder, Chairman of the Scientific Advisory Board)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for BeiGene, Ltd.
(ONC) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.